GlassScriptPhysician profile
Scott Ronald Barnes
NPI 1215102298
$1,462.42
in general payments reported to CMS, 2019-2025
9 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
See the full distribution for Corneal and Contact Management
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2021: $557 · 2022: $287 · 2023: $287 · 2024: $15.60 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363 · Entertainment: $57.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.89 |
| Entertainment | $57.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $448.88 | 2019-2025 | |
| Alcon Vision LLC | $268.30 | 2019-2025 | Clareon, Precision7, Argos |
| Intuitive Surgical, INC. | $194.57 | 2021 | |
| Rxsight INC | $176.57 | 2021-2023 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Biotissue Holdings INC. | $139.96 | 2021 | |
| Optos, INC. | $122.65 | 2022-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $47.04 | 2023 | Myday Contact Lens |
| Hoffmann-La Roche Limited | $46.20 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $18.25 | 2023 | Acuvue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.